Abstract

Ten elite maize inbred lines were selected based on all over per se performance and gray leaf spot disease reaction. Crosses were made in a 10 × 10 half-diallel mating design to produce 45 F1 single cross hybrids. The experiment was conducted at Bako national maize research center in 2015 and evaluation of the crosses were made at Bako and Jimma research centers in 2016 by using alpha lattice design with three replications including three commercial checks. All the necessary yield, agronomic and GLS disease data were recorded. In all the studied traits highly significant genotypic differences were observed indicating the existence of genetic variability among the crosses. Analysis of variance for the combining ability indicated GCA and SCA mean squares were significant at (P < 0.001) for all traits except for anthesis-silking interval, ear per plant, ear diameter, lesion length and width. The ratios of GCA/SCA variances for agronomic parameters and all disease parameters were greater than unity except for that of first disease appearance implying the predominance of additive gene actions. Among all inbred lines, P1, P4, P7, P8 and P9 were identified as desirable sources of resistant genes for GLS disease resistance with positive days of first disease appearance and negative disease incidence, severity and AUDPC values for GCA effects. From the analysis of epidemiological data and disease progress curves the Logistic model (R2 = 96.5) better described the disease progress curves than the Gompertz model (R2 = 92.5) indicating the presence of delayance in epidemics and the inflection point of the GLS. P1, P7 and P8 were identified as a good general combiners for yield, yield related traits and GLS disease parameters. Thus, these parents were recommended to be used in breeding programs with a purpose of developing high yielder and GLS resistant single cross hybrids. In conclusion this study identified potential high yielding and GLS resistant single cross hybrids (CML-395/CML-383, CML-395/Sc-22, CML-395/CML-197 and CML-383/CML-197). Therefore, it is recommended that these hybrids can be used for direct production where this disease is the most prevalent and/or for further breeding programs in generating novel hybrids for future use.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.